Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

VACOPAN INJECTION 20 mg/ml - HSA Drug Approval Details

Approvals/HSA/VACOPAN INJECTION 20 mg/ml

Approved

THERAPEUTIC

VACOPAN INJECTION 20 mg/ml

ATLANTIC LABORATORIES CORPN LTD🇸🇬 Health Sciences Authority

Approval Date: Nov 25, 1997
Approval ID: a710a397f96327f6
Company: ATLANTIC LABORATORIES CORPN LTD
Type: Therapeutic

Approval Details

Approval Id: a710a397f96327f6
Drug Name: VACOPAN INJECTION 20 mg/ml
Product Name: VACOPAN INJECTION 20 mg/ml
Approval Number: SIN09563P
Approval Date: 1997-11-25
Registrant: ATLANTIC PHARMACEUTICAL (S) PTE LTD
Licence Holder: ATLANTIC PHARMACEUTICAL (S) PTE LTD
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: INJECTION
Route Of Administration: INTRAVENOUS, SUBCUTANEOUS, INTRAMUSCULAR
Atc Code: A03BB01
Atc Item Name: butylscopolamine
Pharma Manufacturer Name: atlantic pharmaceutical (s) pte ltd

Active Ingredients

HYOSCINE N-BUTYLBROMIDE

20 mg/ml

HYOSCINE N-BUTYLBROMIDE

20 mg/ml

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Nov 25, 1997

Approval ID

a710a397f96327f6

Type

Therapeutic

Back to HSA Approvals